Evotec SE (EVO)
5.25
-0.24
(-4.37%)
USD |
NASDAQ |
May 17, 16:00
5.26
+0.01
(+0.19%)
After-Hours: 20:00
Evotec Total Assets (Quarterly): 2.490B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.490B |
| September 30, 2023 | 2.386B |
| June 30, 2023 | 2.501B |
| December 31, 2022 | 2.421B |
| September 30, 2022 | 2.224B |
| June 30, 2022 | 2.396B |
| March 31, 2022 | 2.439B |
| December 31, 2021 | 2.531B |
| September 30, 2021 | 2.051B |
| June 30, 2021 | 1.929B |
| March 31, 2021 | 1.853B |
| December 31, 2020 | 1.799B |
| September 30, 2020 | 1.373B |
| June 30, 2020 | 1.339B |
| March 31, 2020 | 1.305B |
| December 31, 2019 | 1.323B |
| September 30, 2019 | 1.186B |
| June 30, 2019 | 1.214B |
| March 31, 2019 | 989.16M |
| December 31, 2018 | 882.96M |
| September 30, 2018 | 895.14M |
| June 30, 2018 | 802.14M |
| March 31, 2018 | 820.25M |
| December 31, 2017 | 799.57M |
| September 30, 2017 | 758.69M |
| Date | Value |
|---|---|
| June 30, 2017 | 482.15M |
| March 31, 2017 | 447.49M |
| December 31, 2016 | 374.35M |
| September 30, 2016 | 309.83M |
| June 30, 2016 | 302.40M |
| March 31, 2016 | 311.62M |
| December 31, 2015 | 315.46M |
| September 30, 2015 | 320.11M |
| June 30, 2015 | 326.02M |
| March 31, 2015 | 246.90M |
| December 31, 2014 | 273.12M |
| September 30, 2014 | 271.10M |
| June 30, 2014 | 300.99M |
| March 31, 2014 | 302.05M |
| December 31, 2013 | 313.98M |
| September 30, 2013 | 331.79M |
| June 30, 2013 | 282.26M |
| March 31, 2013 | 284.44M |
| December 31, 2012 | 298.13M |
| September 30, 2012 | 293.83M |
| June 30, 2012 | 268.41M |
| March 31, 2012 | 285.22M |
| December 31, 2011 | 282.65M |
| September 30, 2011 | 289.18M |
| June 30, 2011 | 290.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.186B
Minimum
Sep 2019
2.531B
Maximum
Dec 2021
1.931B
Average
1.990B
Median
Total Assets (Quarterly) Benchmarks
| Centogene NV | 85.29M |
| Affimed NV | 107.40M |
| InflaRx NV | 115.65M |
| MorphoSys AG | 2.240B |
| BioNTech SE | 24.04B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.252B |
| Shareholders Equity (Quarterly) | 1.238B |
| Debt to Equity Ratio | 0.5592 |
| Current Ratio | 1.944 |
| Net Debt Paydown Yield | -1.69% |